C07D 241/32
Guanidines
Official title: (Amino-pyrazinoyl) guanidines
C07D241/32 (Guanidines) appears on 45 US grants and 63 published applications in this corpus.
Search patents in C07D- Granted patents
- 45
- Published applications
- 63
- Assignees
- 10
- Inventors
- 32
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 4 |
| 2005 | 1 | 3 |
| 2006 | 1 | 4 |
| 2007 | 4 | 1 |
| 2008 | 5 | 5 |
| 2009 | 0 | 5 |
| 2010 | 0 | 1 |
| 2011 | 2 | 3 |
| 2012 | 5 | 1 |
| 2013 | 2 | 2 |
| 2014 | 2 | 6 |
| 2015 | 5 | 8 |
| 2016 | 2 | 3 |
| 2017 | 5 | 5 |
| 2018 | 5 | 2 |
| 2019 | 3 | 4 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Pyrazinecarboxamide analog compounds for use in treating cancer16 Jun 2026US 12,655,131 B2
- Purification of substituted diaminopyrazine dicarboxylic acids30 Sep 2025US 12,428,382 B2MediBeacon Inc.
- Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases7 Jan 2020US 10,526,292 B2Parion Sciences, Inc.
- 3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds2 Apr 2019US 10,246,425 B2Parion Sciences, Inc.
- Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds19 Mar 2019US 10,233,158 B2Parion Sciences, Inc.
- Pyrazinecarboxamide analog compounds for use in treating cancer1 Oct 2026US 2026/0297064 A1Novapano LLC
- Biphenyl-substituted epithelial sodium channel blocking compounds10 Apr 2025US 2025/0115561 A1Parion Sciences, Inc.
- N-acylhydrazone compounds capable of inhibiting nav1.7 and/or nav1.8, processes for the preparation thereof, compositions, uses, methods for treatment using same, and kits10 Oct 2024US 2024/0335442 A1Eurofarma Laboratorios SA
- Compounds and uses thereof5 Jan 2023US 2023/0002356 A1Pano Therapeutics, Inc.
- Purification of substituted diaminopyrazine dicarboxylic acids6 Oct 2022US 2022/0315538 A1MediBeacon Inc.
Most cited
By later US patents
- Phenyl guanidine sodium channel blockers69US 6,858,615 B2Parion Sciences, Inc. · 2005
- Sodium channel blockers55US 7,192,960 B2Parion Sciences, Inc. · 2007
- Sodium channel blockers53US 7,186,833 B2Parion Sciences, Inc. · 2007
- Sodium channel blockers53US 7,189,719 B2Parion Sciences, Inc. · 2007
- Capped pyrazinoylguanidine sodium channel blockers52US 7,064,129 B2Parion Sciences, Inc. · 2006